title: Prevention agenda for genital herpes.
abstract: Few meeting participants envisioned a prevention and control program on the scale or scope of CDC's programs to prevent HIV infection, syphilis, gonorrhea, and chlamydial infection, but all agreed that the virtual absence of public health interventions to prevent genital herpes is no longer appropriate in light of evolving epidemiologic knowledge and other research advances. The ultimate scope of a national genital herpes prevention effort will depend in part on the results of the recommended research agenda, which probably will evolve over the better part of a decade. Numerous other STD prevention partners will also need to contribute to this effort and help to determine the makeup of future programs. Substantial new fiscal resources will be required both to implement the proposed research agenda and, depending on the results, to undertake the prevention efforts indicated by those studies. Competing STD prevention priorities and other national health needs will influence the availability of those resources. The consultants' meeting and the research and program activities summarized above are described in more detail in the full meeting report, which is posted on the Division's web site (www.cdc.gov/nchstp/dstd/dstdp.html) or may be requested directly from the Division. DSTDP is interested in receiving comments and suggestions about herpes prevention.
authors.affiliation: Division of Sexually Transmitted Diseases Prevention, Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, U.S. Public Health Service, Atlanta, Georgia, USA. hhh@u.washington.edu
authors.forename: H H
authors.initials: HH
authors.lastname: Handsfield
authors.forename: K M
authors.initials: KM
authors.lastname: Stone
authors.forename: J N
authors.initials: JN
authors.lastname: Wasserheit
mesh_terms: D000914:Antibodies, Viral / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use; D002487:Centers for Disease Control and Prevention, U.S.; D006558:Herpes Genitalis / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control* / Q000523:psychology / Q000821:virology; D018258:Herpesvirus 2, Human / Q000276:immunology*; D006801:Humans; D007231:Infant, Newborn; D017053:Infection Control / Q000379:methods; D012106:Research; D012731:Sex Counseling; D014481:United States
chemical_list: D000914:Antibodies, Viral; D000998:Antiviral Agents